VRTX VERTEX PHARMACEUTICALS INC Company Mergers 8-K Filing 2024 - Acquisition Vertex Pharmaceuticals Inc completed its acquisition of Alpine Immune Sciences Inc for $5.0 billion in cash, which will impact its financials for the second quarter and full year 2024.Get access to all SEC 8-K filings of the VERTEX PHARMACEUTICALS INC